|
UNITED
STATES FORM 10-Q |X|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OR |_|
TRANSACTION REPORT PURSUANT TO SECTION 13 OR 15(d) For the transition period from _______ to _______Commission File number # 000-24547Scientific Learning Corporation |
| Delaware | 94-3234458 |
| (State or other jurisdiction
of incorporation or organization) |
(I.R.S. Employer Identification No.) |
| 300
Frank H. Ogawa Plaza, Suite 600 Oakland, California 94612 (510) 444-3500 (Address of Registrants principal executive offices, including zip code, and telephone number, including area code) |
|
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes |X| No |_| Indicate by check mark whether the Registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes |_| No |X| The number of shares of the Registrants Common Stock, $.001 par value per share, outstanding at April 30, 2004 was 16,159,747 |
|
|
SCIENTIFIC LEARNING CORPORATION INDEX
TO FORM 10-Q |
| PAGE | |||
| PART 1. FINANCIAL INFORMATION | |||
| Item 1 | Condensed Financial Statements: | ||
| Condensed Balance Sheets as of March 31, 2004 and December 31, 2003 | 3 | ||
| Condensed Statement of Operations for the Three Months | |||
| Ended March 31, 2004 and 2003 | 4 | ||
| Condensed Statements of Cash Flows for the Three Months | |||
| Ended March 31, 2004 and 2003 | 5 | ||
| Notes to Condensed Financial Statements | 6 | ||
| Item 2 | Managements Discussion and Analysis of Financial Condition | ||
| and Results of Operations | 10 | ||
| Item 3 | Quantitative and Qualitative Disclosures about Market Risk | 17 | |
| Item 4 | Controls and Procedures | 17 | |
| PART II. OTHER INFORMATION | |||
| Item 6 | Exhibits and Reports on Form 8-K | 18 | |
| Signature | 22 |
|
Page 2 |
PART I. FINANCIAL INFORMATION |
| SCIENTIFIC
LEARNING CORPORATION CONDENSED BALANCE SHEETS (In thousands) |
| March
31, 2004 |
December
31, 2003 |
||||||
| (unaudited) | |||||||
| Assets | |||||||
| Current assets: | |||||||
| Cash and cash equivalents | $ | 3,089 | $ | 3,648 | |||
| Accounts receivable, net | 4,494 | 5,117 | |||||
| Prepaid expenses and other current assets | 1,191 | 1,134 | |||||
| Total current assets | 8,774 | 9,899 | |||||
| Property and equipment, net | 572 | 537 | |||||
| Notes receivable from current and former officers | 3,114 | 3,114 | |||||
| Other assets | 1,971 | 2,004 | |||||
| Total assets | $ | 14,431 | $ | 15,554 | |||
| Liabilities and stockholders deficit | |||||||
| Current liabilities: | |||||||
| Accounts payable | $ | 456 | $ | 481 | |||
| Accrued liabilities | 2,930 | 3,832 | |||||
| Borrowings under bank line of credit | 2,600 | | |||||
| Deferred revenue | 13,353 | 16,233 | |||||
| Total current liabilities | 19,339 | 20,546 | |||||
| Deferred revenue, long-term | 1,409 | 1,289 | |||||
| Other liabilities | 295 | 285 | |||||
| Total liabilities | 21,043 | 22,120 | |||||
| Stockholders deficit: | |||||||
| Common stock | 74,577 | 74,460 | |||||
| Accumulated deficit | (81,189 | ) | (81,026 | ) | |||
| Total stockholders deficit | (6,612 | ) | (6,566 | ) | |||
| Total liabilities and stockholders deficit | $ | 14,431 | $ | 15,554 | |||
| See accompanying notes to condensed financial statements. |
|
Page 3 |
| SCIENTIFIC
LEARNING CORPORATION CONDENSED STATEMENT OF OPERATIONS (In thousands, except share and per share amounts) unaudited |
| Three months ended March 31, | ||||||
| 2004 | 2003 | |||||
| Revenues: | ||||||
| Products | $ | 5,313 | $ | 5,331 | ||
| Service and support | 1,828 | 1,046 | ||||
| Total revenues | 7,141 | 6,377 | ||||
| Cost of revenues: | ||||||
| Cost of products | 322 | 454 | ||||
| Cost of services and support | 1,219 | 929 | ||||
| Total cost of sales | 1,541 | 1,383 | ||||
| Gross profit | 5,600 | 4,994 | ||||
| Operating expenses: | ||||||
| Sales and marketing | 3,823 | 3,273 | ||||
| Research and development | 885 | 909 | ||||
| General and administrative | 1,011 | 1,112 | ||||
| Total operating expenses | 5,719 | 5,294 | ||||
| Operating loss | (119 | ) | (300 | ) | ||
| Other income from related party | 35 | | ||||
| Interest expense, net | (79 | ) | (310 | ) | ||
| Net loss | $ | (163 | ) | $ | (610 | ) |
| Basic and diluted net loss per share | $ | (0.01 | ) | $ | (0.04 | ) |
| Shares used in computing basic and diluted | ||||||
| net loss per share | 16,153,843 | 15,879,655 | ||||
| See accompanying notes to condensed financial statements. |
|
Page 4 |
| SCIENTIFIC
LEARNING CORPORATION CONDENSED STATEMENTS OF CASH FLOWS (In thousands) unaudited |
| Three months ended March 31, | ||||||
| 2004 | 2003 | |||||
| Operating Activities: | ||||||
| Net loss | $ | (163 | ) | $ | (610 | ) |
| Adjustments to reconcile net loss to cash used in operating activities: | ||||||
| Depreciation and amortization | 180 | 316 | ||||
| Amortization of deferred financing costs | 99 | 304 | ||||
| Stock based compensation | 96 | 7 | ||||
| Changes in operating assets and liabilities: | ||||||
| Accounts receivable | 623 | 1,511 | ||||
| Prepaid expenses and other current assets | (156 | ) | 49 | |||
| Accounts payable | (25 | ) | 217 | |||
| Accrued liabilities | (903 | ) | (1,200 | ) | ||
| Deferred revenue | (2,760 | ) | (2,917 | ) | ||
| Other liabilities | 10 | 64 | ||||
| Net cash used in operating activities | (2,999 | ) | (2,259 | ) | ||
| Investing Activities: | ||||||
| Purchases of property and equipment, net | (143 | ) | (23 | ) | ||
| Other non-current assets | (38 | ) | (38 | ) | ||
| Net cash used in investing activities | (181 | ) | (61 | ) | ||
| Financing Activities: | ||||||
| Proceeds from issuance of common stock | 21 | | ||||
| Borrowings under bank line of credit | 2,600 | 1,300 | ||||
| Repayments on borrowings under bank line of credit | | | ||||
| Net cash provided by financing activities | 2,621 | 1,300 | ||||
| Decrease in cash and cash equivalents | (559 | ) | (1,020 | ) | ||
| Cash and cash equivalents at beginning of the period | 3,648 | 4,613 | ||||
| Cash and cash equivalents at end of the period | $ | 3,089 | $ | 3,593 | ||
| Supplemental disclosure: | ||||||
| Interest Paid | $ | 1 | $ | 42 | ||
| See accompanying notes to condensed financial statements. |
|
Page 5 |
| March 31, 2004 |
December
31, 2003 |
|||||
|---|---|---|---|---|---|---|
| Software development costs | $ | 3,089 | $ | 3,089 | ||
| Less accumulated amortization | (2,450 | ) | (2,379 | ) | ||
| Software development costs, net | 639 | 710 | ||||
| Other non current assets | 1,332 | 1,294 | ||||
| $ | 1,971 | $ | 2,004 | |||
|
Page 6 |
Notes to Condensed Financial Statements 1. Summary of Significant Accounting Policies (continued) Accrued restructuring costs In October 2003 the Company entered into an agreement with its landlord to terminate the lease for its Oakland headquarters and commence a new lease agreement for a reduced amount of space in the same building. This reduction in space is expected to decrease total lease payments by approximately $6.5 million (net of lease termination fees described below) through 2008. Under these agreements the Company paid an increased security deposit of $550,000 and lease termination fees totaling $930,000 through March 31, 2004. The balance of the lease termination fee, $1.3 million, will be paid in equal monthly installments through December 31, 2004. The term of the new lease agreement expires December 31, 2013. The following table
sets forth the restructuring activity during the quarter ended March 31,
2004 |
| Accrued restructuring costs, beginning of the period |
Cash paid | Accrued restructuring costs, end of the period |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| Lease obligations | $ | 1,773 | (445 | ) | $ | 1,328 | |||
Net Loss Per Share Basic and diluted net
loss per share information for all periods is presented under the requirements
of Statement of Financial Accounting Standards No. 128, Earnings
per Share. Basic net loss per share has been computed using the
weighted-average number of shares outstanding during the period and excludes
any dilutive effects of stock options and warrants. Potentially
dilutive securities have been excluded from the computation of diluted
net loss per share, as their inclusion would be antidilutive. Stock-Based Compensation The Company has elected to use the intrinsic value method in accounting for its employee stock options because the alternative, fair value accounting requires the use of option valuation models that were not developed for use in valuing employee stock options. Under the intrinsic value method, when the exercise price of the Companys employee stock options equals the market price of the underlying stock on the date of grant, no compensation expense is recognized. Had compensation cost for the Companys stock-based compensation plans been determined using the fair value at the grant dates for awards under those plans calculated using the Black-Scholes valuation model, |
|
Page 7 |
Notes to Condensed Financial Statements 1. Summary of Significant Accounting Policies (continued) The Companys net loss and basic and diluted net loss per share would have been increased to the pro forma amounts indicated below (in thousands, except per share amounts): |
| March 31, | ||||||
|---|---|---|---|---|---|---|
| 2004 | 2003 | |||||
| Net loss, as reported | $ | (163 | ) | $ | (610 | ) |
| Add: Stock-based employee compensation expense | ||||||
| included in the determination of net loss, as | ||||||
| reported | | | ||||
| Deduct: Total stock-based employee compensation | ||||||
| expense determined under fair value based method | ||||||
| for all awards | (321 | ) | (358 | ) | ||
| Net loss, proforma | $ | (484 | ) | $ | (968 | ) |
| Basic and diluted net loss per share, as reported | $ | (0.01 | ) | $ | (0.04 | ) |
| Basic and diluted net loss per share, pro forma | $ | (0.03 | ) | $ | (0.06 | ) |
The fair value of the options was estimated using the following assumptions: a risk free interest rate of 3%, no dividend yield, a volatility factor of 85% and a weighted average expected life of the options of five years. The pro forma impact of options on the net loss for the three months ended March 31, 2004 and 2003 is not representative of the effects on net loss for future periods, as future years will include the effects of additional periods of stock option grants. 2. Comprehensive Loss The Company has no items of other comprehensive loss, and accordingly the comprehensive loss is equal to the net loss for all periods reported. 3. Guarantees The Company generally provides a warranty for its software products to its customers and accounts for its warranties under the FASBs Statement of Financial Accounting Standards No. 5, Accounting for Contingencies (FAS No.5) under which estimated losses are recorded if it is probable a liability has been incurred and the amount of the loss can be reasonably estimated. Warranty periods can vary from customer to customer but our standard warranty period is 90 days. In the event there is a failure of the product in breach of such warranties, the Company generally is obligated to correct the product or service to conform to the warranty provision or, if the Company is unable to do so, the customer is entitled to seek a refund of the purchase price of the product. The Company did not provide for a warranty accrual as of March 31, 2004. To date, the Companys product warranty expense has not been significant. |
|
Page 8 |
4. Related Party Transaction In September 2003 the Company entered into an agreement with Neuroscience Solutions Corporation (NSC) to provide NSC with exclusive rights in the healthcare field to certain intellectual property, patents and software owned or licensed by the Company, along with transfer of certain healthcare research projects. A co-founder, substantial shareholder, and member of the Board of Directors of the Company is a co-founder, officer, director and substantial shareholder of NSC. For the three months ended March 31, 2004 the Company recognized $35,000 in other income for service provided to NSC and royalties for product licenses. |
|
Page 9 |
| Three months ended March 31 | ||||||||
|---|---|---|---|---|---|---|---|---|
| (dollars in thousands) | 2004 | Change | 2003 | |||||
| Products | $ | 5,313 | 0 | % | $ | 5,331 | ||
| Service and support | 1,828 | 75 | % | 1,046 | ||||
| Total revenues | $ | 7,141 | 12 | % | $ | 6,377 | ||
| Revenues: The growth in revenues for the three months ended March 31, 2004 was attributable to 75% increase in services and support. Product revenues were approximately equal to product revenue in the same period in 2003, largely the result of slow fourth quarter 2003 sales and a shift in our sales mix towards more services and support. Service and support revenues increased primarily due to increased delivery of on-site services. Service and support revenue also grew as a result of the increase in the number of schools on support contracts. |
|
Page 10 |
Booked sales and selling activity: Because a significant portion of our software, services and support revenue is recognized in periods after the invoice date, management uses booked sales to evaluate current selling activity. Booked sales is a non-GAAP financial measure that we believe is useful for investors as well as management as a measure of current demand for our products and services. Booked sales equals the total value (net of allowances) of software, services and support invoiced in the period. We record booked sales and deferred revenue when all of the requirements for revenue recognition have been met, other than the requirement that the revenue for software licenses and services has been earned. We use booked sales information for resource allocation, planning, compensation and other management purposes. However, booked sales should not be considered in isolation from, and is not intended to represent a substitute measure of revenues or any other performance measure calculated under GAAP. The following reconciliation table sets forth our booked sales, revenues and change in deferred revenue for the quarters ended March 31, 2004 and 2003. |
| Quarter ended March 31, | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| (dollars in thousands) | 2004 | Change | 2,003 | ||||||
|
|
|||||||||
| Booked sales | $ | 4,381 | 27 | % | $ | 3,461 | |||
| Less revenue | 7,141 | 12 | % | 6,377 | |||||
| Net increase/(decrease) in deferred revenue | (2,760 | ) | (2,916 | ) | |||||
| Current and long-term deferred revenue beginning of the period | 17,522 | 15,584 | |||||||
| Current and long-term deferred revenue end of the period | $ | 14,762 | 17 | % | $ | 12,668 | |||
Booked sales in the K-12 sector, which accounted for 91% of booked sales in the first quarter of 2004, grew 28% to $4.0 million, compared to $3.1 million in the same period in 2003, primarily due to the growth in service and support sales. Booked sales to non-school customers, primarily private practice clinicians, improved by 15% to $376,000 in the first quarter of 2004, compared to $326,000 in 2003. Our focus continues to be on K-12 sales; sales to non-school customers have declined over the past several years. In 2004, we plan to continue to concentrate our sales effort on large multiple-site opportunities in the K-12 market. We believe large sales are an important indicator of mainstream education industry acceptance and an important factor in continuing to increase the productivity of our sales force. During the first quarter of 2004, we closed four transactions which had a contract value in excess of $100,000 compared to three during the same period in 2003. We believe that our new update to the Gateway Edition has resolved most of the technical issues we experienced in the second half of 2003. Although federal, state and local budget pressures make for an uncertain funding environment for our customers, we believe that we are positioned to achieve continued growth in the K-12 market during 2004. We expect that the sales of services will continue to grow as a percent of total sales on a year-over-year basis. Unpredictability : To achieve our sales growth objectives will depend on increasing mainstream customer acceptance of our products, which requires us to continue to focus on improving our products ease of use, their fit with school requirements, and our connection with classroom teachers and administrators. Our sales force numbers are limited, which requires us to achieve increased sales productivity levels, in a K-12 market that is still negatively impacted by tight state and local funding. For a discussion of some of the other important factors that affect our results, see Factors that May Affect Results of Operations or Stock Price. In addition, the revenue recognized from our sales can be unpredictable. Our various license and service packages have substantially differing revenue recognition periods, and it is often difficult to predict which license package a customer will purchase, even when the amount and timing of a sale can be reasonably projected. See Managements Discussion and Analysis Application of Critical Accounting Policies for a discussion of our revenue recognition policy. In addition, the timing of a single large order or its implementation can significantly impact the level of sales and revenue at any given time. Booked sales tend to be seasonal in nature and the first quarter booked sales typically are the lowest of the year. |
|
Page 11 |
| Gross Profit and Cost of Revenues |
| Quarter Ended March 31, | ||||||||||||
| 2004 | 2003 | |||||||||||
| (dollars in thousands) | $ Profit | Margin % | $ Profit | Margin % | ||||||||
| Gross profit on products | $ | 4,991 | 94 | % | $ | 4,877 | 91 | % | ||||
| Gross profit on services and support | $ | 609 | 33 | % | $ | 117 | 11 | % | ||||